McDiarmid et al. 2021. Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes

This pilot randomised control trial tests the feasibility and potential efficacy of remotely supported intermittent low-energy diets (ILEDs) and continuous low-energy diets (CLEDs) in people with type 2 diabetes (T2D). The study demonstrated feasibility and efficacy for remote ILEDs and CLEDs for weight loss and HbA1c reduction.